ASPI Form 144: 1.44M Shares Proposed for Sale

Independent Trading Group Inc. (ASPI) filed a Form 144 reporting a proposed sale of 1,441,361 shares of common stock, listed as acquired as compensation under a restricted stock award on 04/14/2025.

Rhea-AI Filing Summary

Independent Trading Group Inc. (ASPI) filed a Form 144 reporting a proposed sale of 1,441,361 shares of common stock, listed as acquired as compensation under a restricted stock award on 04/14/2025.

The filing identifies the securities as common stock to be sold through NASDAQ and cites the 04/14/2025 grant date; cash‑flow treatment and exact planned sale timing are not shown in the excerpt.

Insights

Securities Compliance Attorney

Form 144 notifies the market of an affiliate's intent to sell 1,441,361 shares acquired as a restricted award.

Form 144 is a notice required when an affiliate intends to sell restricted or control securities in reliance on Rule 144; the excerpt lists 1,441,361 shares tied to a 04/14/2025 restricted stock award. This does not itself effect a sale; it signals a proposed disposition subject to Rule 144 conditions.

Execution depends on meeting holding‑period, public‑information, and manner‑of‑sale requirements; subsequent filings (e.g., Form 4, broker records) would show actual transactions and timing.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does ASPI's Form 144 report?

The filing reports a proposed sale of 1,441,361 shares of common stock, acquired as a restricted stock award on 04/14/2025. It notifies the market of an affiliate's intent to sell under Rule 144.

Does Form 144 mean the shares have already been sold?

No. Form 144 is a notice of intended sale; it does not confirm a completed transaction. Completion would be reflected in later filings such as Form 4 or broker reports.

Who is the issuer named on the Form 144 for ASPI?

The issuer named is Independent Trading Group (ITG) Inc., with securities listed for sale on NASDAQ. The excerpt shows the issuer address and exchange listing.

What information ties the shares to compensation?

The shares are listed as acquired as compensation under a Restricted Stock Award with an acquisition date of 04/14/2025, per the filing's securities description.

Will the Form 144 disclose how proceeds are used?

No. The excerpt does not state the use of proceeds or cash‑flow recipients. Use of proceeds is not typically disclosed on Form 144.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/02/2026 - 09:45 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001744816
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	ASP Isotopes Inc.
SEC File Number	001-41555
Address of Issuer	2200 Ross Avenue Suite 4575E Dallas TEXAS 75201
Phone	2144328219
Name of Person for Whose Account the Securities are To Be Sold	Mann Paul Elliot
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	DIRECTOR
Relationship to Issuer	OFFICER

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Independent Trading Group (ITG) Inc. 33 Yonge Street Suite Suite 420 Toronto A6 A6 M5E 1	162153	865897	110840122	03/02/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	04/14/2025	Acquired as compensation --Restricted Stock Award	Issuer			1441361	04/14/2025	Equity Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks	The sale of shares reported in this Form 144 includes an amount for the purpose of satisfying the Reporting Person's income tax liabilities resulting from the quarterly vesting of a previously granted restricted stock award for 1,441,361 shares pursuant to an issuer equity incentive plan. The Aggregate Market Value of the shares to be sold is based on the closing market price of $5.34 on February 27, 2026.
Date of Notice	03/02/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	06/09/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Paul Elliot Mann
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)